Package 43598-625-30

{"route": ["ORAL"], "spl_id": "67155108-ea36-1f02-9acd-46329845e85c", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0343598626307", "0343598624303", "0343598625300"], "unii": ["0K2I505OTV", "0H73WJJ391"], "rxcui": ["1302827", "1302839", "1302850", "1313059"], "spl_set_id": ["260c3f90-163d-0bdd-1099-55d18a900e68"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (43598-625-30)", "package_ndc": "43598-625-30", "marketing_start_date": "20250601"}], "brand_name": "Phentermine and Topiramate Extended-Release", "product_id": "43598-625_67155108-ea36-1f02-9acd-46329845e85c", "dosage_form": "CAPSULE", "pharm_class": ["Appetite Suppression [PE]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "43598-625", "dea_schedule": "CIV", "generic_name": "Phentermine and Topiramate Extended-Release", "labeler_name": "Dr.Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine and Topiramate Extended-Release", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "7.5 mg/1"}, {"name": "TOPIRAMATE", "strength": "46 mg/1"}], "application_number": "ANDA208175", "marketing_category": "ANDA", "marketing_start_date": "20250601", "listing_expiration_date": "20261231"}